Lisi Emily C, Gillespie Scott, Laney Dawn, Ali Nadia
Emory University School of Medicine, Department of Human Genetics, 2165 N. Decatur Rd., Decatur, GA 30033, USA.
Emory University School of Medicine, Pediatric Research Center, 2015 Uppergate Rd., Atlanta, GA 30322, USA.
Mol Genet Metab. 2016 Sep;119(1-2):109-14. doi: 10.1016/j.ymgme.2016.07.009. Epub 2016 Jul 21.
Lysosomal storage diseases (LSDs) are an individually rare but collectively common group of hereditary, progressive, multi-systemic disorders. Recent technological advances have brought newborn screening (NBS) for LSDs to attention in the United States. However, many LSD symptoms present in later childhood or adulthood, with a wide spectrum of severity. Because late-onset symptoms stray from the traditional NBS model, healthcare providers have expressed concerns about potential harm to patients and/or their families. In this study, 47 individuals with Fabry disease (FD), 22 with Gaucher disease (GD), and 22 with late-onset Pompe disease (LOPD) were surveyed regarding how their life might have been impacted by NBS. Of the 91 participants, none had symptoms at birth and 42 (46.7%) were symptom-free until adulthood. Over half (52.8%) were diagnosed ≥5years from symptom onset; of these, significantly more had FD (60%) or LOPD (63.6%) than GD (23.8%). However, length of diagnostic odyssey was not significantly correlated with opinion on NBS. Most participants either strongly agreed (45%) or agreed (33.3%) with NBS for their condition, with no significant differences between diseases. Opinions on NBS were correlated with participants' opinions on whether NBS would have resulted in better current health, but uncorrelated with disease severity or current life satisfaction. Significantly more participants with FD (42.6%) and LOPD (63.6%) than GD (13.6%) felt they would have greater life satisfaction had they been diagnosed as a newborn (p=0.007). Almost half (41%) of participants would have made different life decisions, including lifestyle, financial, and reproductive decisions. Regarding potential harm, participants were most concerned about insurability and least concerned about removal of children's autonomy. In conclusion, NBS is highly approved of among individuals with LSDs themselves, as it would significantly eliminate diagnostic odysseys and potentially alter life planning.
溶酶体贮积症(LSDs)是一组各自罕见但总体上较为常见的遗传性、进行性、多系统疾病。最近的技术进步使美国开始关注对溶酶体贮积症的新生儿筛查(NBS)。然而,许多溶酶体贮积症症状出现在儿童期后期或成年期,严重程度范围广泛。由于迟发性症状偏离了传统的新生儿筛查模式,医疗服务提供者对患者及其家庭可能受到的潜在伤害表示担忧。在本研究中,对47例法布里病(FD)患者、22例戈谢病(GD)患者和22例迟发性庞贝病(LOPD)患者进行了调查,了解新生儿筛查可能对他们生活产生的影响。在91名参与者中,没有人在出生时出现症状,42人(46.7%)直到成年都没有症状。超过一半(52.8%)的患者在出现症状后≥5年才被诊断;其中,法布里病(60%)或迟发性庞贝病(63.6%)患者被诊断的时间明显多于戈谢病患者(23.8%)。然而,诊断过程的时长与对新生儿筛查的看法没有显著相关性。大多数参与者要么强烈同意(45%)要么同意(33.3%)针对其病情进行新生儿筛查,不同疾病之间没有显著差异。对新生儿筛查的看法与参与者对新生儿筛查是否会带来更好的当前健康状况的看法相关,但与疾病严重程度或当前生活满意度无关。与戈谢病患者(13.6%)相比,明显更多的法布里病患者(42.6%)和迟发性庞贝病患者(63.6%)认为如果他们在新生儿期就被诊断,生活满意度会更高(p=0.007)。几乎一半(41%)的参与者会做出不同的生活决策,包括生活方式、财务和生育决策。关于潜在危害,参与者最担心保险问题,最不担心剥夺儿童的自主权。总之,溶酶体贮积症患者自身对新生儿筛查高度认可,因为它将显著消除诊断过程,并可能改变生活规划。